380550 — Neurophet Cashflow Statement
0.000.00%
- KR₩166bn
- KR₩165bn
- KR₩2bn
Annual cashflow statement for Neurophet, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | — | 5,263 | -15,101 |
Depreciation | |||
Amortisation | |||
Non-Cash Items | — | -15,891 | 1,080 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -7,931 | 628 | 313 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -7,931 | -8,974 | -12,613 |
Capital Expenditures | -354 | -313 | -393 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 7,610 | -5,621 | 9,011 |
Sale of Fixed Assets | |||
Sale/Maturity of Investment | |||
Purchase of Investments | |||
Sale of Intangible Assets | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 7,256 | -5,934 | 8,618 |
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 264 | 19,753 | 342 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | -412 | 4,845 | -3,652 |